King Jeffery L, Guidry Clyde
Department of Ophthalmology, University of Alabama School of Medicine, Birmingham, 35294, USA.
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2848-55. doi: 10.1167/iovs.04-0054.
Müller cells are consistently identified in diabetic fibrocontractive ocular tissues and, in response to insulin-like growth factor I, generate tractional forces of the type that cause retinal detachment. Recent studies suggest that diabetes-associated increases in vitreous insulin-like growth factor activity cannot be attributed to simple increases in concentration alone, suggesting that more complex biochemical changes in vitreous growth factor control mechanisms are involved. The goal of this study was to evaluate the contributions of vitreous insulin-like growth factor-binding proteins (IGFBPs) toward control of growth factor activity.
Native and recombinant IGFBPs effects were evaluated on IGF-I- and -II-stimulated Müller cells in tissue culture assays that involved cell incubation on three-dimensional collagen gels and that monitored progressive matrix condensation. IGFBP degradation by Müller cell-secreted proteases was assessed in Western ligand blots, and direct stimulatory effects were evaluated by incubating cells with IGFBPs alone.
IGFBP direct stimulatory effects on Müller cells were significant, but relatively modest, and IGFBP modulation through Müller cell-secreted proteases was undetectable. In contrast, IGFBP inhibitory effects on IGF-I and -II were highly variable and, in some cases, profound. IGFBP-3 effectively inhibited IGF-I and -II stimulation with detectable effects at concentrations equimolar to the growth factor. IGFBP-1, -2, -4, and -5 were of intermediate effectiveness as inhibitors, 3- to 11-fold less active than IGFBP-3. IGFBP-6 had virtually no inhibitory effects on IGF-I, but was moderately effective against IGF-II.
IGFBP effects on IGF-I- and -II-stimulated Müller cells are primarily inhibitory with only modest direct stimulatory effects of limited physiologic relevance. IGFBP-2 and -3, the major binding proteins identified in vitreous, most likely function as the vitreous growth factor sink and control ligand activity through sequestration.
在糖尿病性纤维收缩性眼组织中持续发现 Müller 细胞,并且在胰岛素样生长因子 I 的作用下,产生导致视网膜脱离的那种牵拉力。最近的研究表明,糖尿病相关的玻璃体胰岛素样生长因子活性增加不能仅归因于浓度的简单升高,这表明玻璃体生长因子控制机制涉及更复杂的生化变化。本研究的目的是评估玻璃体胰岛素样生长因子结合蛋白(IGFBPs)对生长因子活性控制的作用。
在组织培养试验中,评估天然和重组 IGFBPs 对胰岛素样生长因子 I 和 II 刺激的 Müller 细胞的影响,该试验包括将细胞在三维胶原凝胶上孵育并监测基质的逐渐凝聚。通过 Western 配体印迹评估 Müller 细胞分泌的蛋白酶对 IGFBP 的降解,并通过单独用 IGFBPs 孵育细胞来评估直接刺激作用。
IGFBPs 对 Müller 细胞的直接刺激作用显著,但相对较小,并且未检测到通过 Müller 细胞分泌的蛋白酶对 IGFBP 的调节作用。相比之下,IGFBPs 对胰岛素样生长因子 I 和 II 的抑制作用变化很大,在某些情况下作用显著。IGFBP-3 有效抑制胰岛素样生长因子 I 和 II 的刺激,在与生长因子等摩尔浓度时具有可检测到的作用。IGFBP-1、-2、-4 和 -5 作为抑制剂的效果中等,活性比 IGFBP-3 低 3 至 11 倍。IGFBP-6 对胰岛素样生长因子 I 几乎没有抑制作用,但对胰岛素样生长因子 II 有中等程度的抑制效果。
IGFBPs 对胰岛素样生长因子 I 和 II 刺激的 Müller 细胞的作用主要是抑制性的,只有适度的直接刺激作用,且生理相关性有限。玻璃体中鉴定出的主要结合蛋白 IGFBP-2 和 -3 最有可能作为玻璃体生长因子的汇,并通过螯合作用控制配体活性。